Boundless Bio, Inc. beat EPS estimates 0% of the time across 2 reported quarters (0 beats, 2 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | — | $-1.06 | — | Miss |
| Q22026 FY2026 | — | $-0.70 | — | Miss |
| Q12026 FY2026 | $-0.51 | $-0.60 | -17.6% | Miss |
| Q42025 FY2025 | $-0.44 | $-0.58 | -31.8% | Miss |
Back to BOLD overview · BOLD holders · BOLD KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.